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Introduction
Selected phthalates have been associated 
with multiple health effects, including 
children’s neuro development (Kim Y et al. 
2011; Whyatt et al. 2012), altered genital 
development (Swan et al. 2005), respira-
tory problems (Jaakkola and Knight 2008), 
oxidative stress (Ferguson et al. 2011), obesity 
(Hatch et al. 2010), and the develop ment of 
diabetes (Svensson et al. 2011). Phthalates are 
used in a wide variety of consumer products 
(Dodson et al. 2012), and their metabolites 
are commonly found in human urine (Koch 
et al. 2011; Langer et al. 2014; Zota et al. 
2014). Several studies have assessed the 
relative contribution of diet, dust ingestion, 
inhalation, or dermal absorption to the total 
level of selected phthalates in humans (Bekö 
et al. 2013; Gaspar et al. 2014; Guo and 
Kannan 2011; Koch et al. 2013; Wittassek 
et al. 2011; Wormuth et al. 2006). Prior to 
2012, assessments of the dermal pathway 
focused on contact transfer, including transfer 
from dust deposited on skin. Kissel (2011) 
argued that dermal absorption has been 
under estimated in many studies that have 
used an inappropriate metric (percent absorp-
tion) to assess dermal uptake. Prompted by 
his critique, there has been recent interest in 
dermal absorption of phthalates and other 
semi volatile organic compounds (SVOCs) 
directly from air (Weschler and Nazaroff 
2012, 2014; Gong et al. 2014b). Numerous 
experimental studies have demonstrated 
that certain volatile organic compounds 
(VOCs) are dermally absorbed from air at 
rates that are comparable to their intake via 
inhalation (e.g., Bader et al. 2008; Piotrowski 
1967, 1971; other references in Weschler 
and Nazaroff 2014). Although fundamental 
physical–chemical considerations indicate 
that the same should be true for certain 
SVOCs, we are aware of no investigations 
that have measured direct dermal uptake 
from air for any SVOC.
Diethyl phthalate (DEP) and di(n-butyl) 
phthalate (DnBP) are among the SVOCs 
predicted to have substantial dermal uptake 
directly from air (Weschler and Nazaroff 
2012, 2014). DEP and DnBP belong 
to the group of so-called low-molecular-
weight phthalates with two and four carbon 
atoms in the alkyl chain, respectively. Their 
chemical and physical properties are summa-
rized in Supplemental Material, Table S1. 
DEP is used in personal care products such 
as cosmetics, perfumes, and shampoos; it is 
also used in the automotive sector and food 
packaging. DnBP is a common ingredient of 
adhesives and coatings and is used as a solvent 
for organic compounds, as an anti foam 
agent, as a fiber lubricant, and as an additive 
in cosmetics, including nail polish (Bolgar 
et al. 2008; Dodson et al. 2012; Wypych 
2012). DEP and DnBP have been identified 
in indoor air and dust samples from around 
the world (e.g., Fromme et al. 2004; Rudel 
et al. 2003; Wensing et al. 2005; Weschler 
and Nazaroff 2008). Their metabolites are 
often the most abundant synthetic chemicals 
identified in human urine (Koch et al. 2011; 
Langer et al. 2014; Zota et al. 2014). The 
aim of the present study was to experimen-
tally evaluate transdermal uptake of DEP and 
DnBP directly from the gas phase based on 
their metabolites in urine. This was accom-
plished by differential inclusion and exclusion 
of the inhalation pathway during repeated 
controlled exposures of human participants in 
a large chamber.
Methods
Human participants. Six healthy males, 
27–66 years of age, agreed to participate 
in these experiments. Their physiological 
parameters are summarized in Supplemental 
Material, Table S2. None had an identified 
skin disease or skin that was compromised 
by a wound. The research protocol was 
approved by the Capital Region of Denmark 
Committee for Research Ethics (case no. 
H-3-2013-196). Participants provided 
informed consent before participation.
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Background: Fundamental considerations indicate that, for certain phthalate esters, dermal 
absorption from air is an uptake pathway that is comparable to or greater than inhalation. Yet this 
pathway has not been experimentally evaluated and has been largely overlooked when assessing 
uptake of phthalate esters.
oBjectives: This study investigated transdermal uptake, directly from air, of diethyl phthalate 
(DEP) and di(n-butyl) phthalate (DnBP) in humans.
Methods: In a series of experiments, six human participants were exposed for 6 hr in a chamber 
containing deliberately elevated air concentrations of DEP and DnBP. The participants either wore 
a hood and breathed air with phthalate concentrations substantially below those in the chamber 
or did not wear a hood and breathed chamber air. All urinations were collected from initiation of 
exposure until 54 hr later. Metabolites of DEP and DnBP were measured in these samples and 
extrapolated to parent phthalate intakes, corrected for background and hood air exposures.
results: For DEP, the median dermal uptake directly from air was 4.0 μg/(μg/m3 in air) compared 
with an inhalation intake of 3.8 μg/(μg/m3 in air). For DnBP, the median dermal uptake from air 
was 3.1 μg/(μg/m3 in air) compared with an inhalation intake of 3.9 μg/(μg/m3 in air).
conclusions: This study shows that dermal uptake directly from air can be a meaningful exposure 
pathway for DEP and DnBP. For other semivolatile organic compounds (SVOCs) whose molecular 
weight and lipid/air partition coefficient are in the appropriate range, direct absorption from air is 
also anticipated to be significant.
citation: Weschler CJ, Bekö G, Koch HM, Salthammer T, Schripp T, Toftum J, 
Clausen G. 2015. Transdermal uptake of diethyl phthalate and di(n-butyl) phthalate directly 
from air: experimental verification. Environ Health Perspect 123:928–934; http://dx.doi.
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Exposure experiments. The six partici-
pants were divided into groups 1 and 2, each 
with three subjects. The exposures occurred 
from 1000 to 1600 hours on Tuesdays and 
Wednesdays of successive weeks and followed 
a crossover design. Group 1 was exposed 
on Tuesdays, with hoods the first week and 
without hoods the second week. Group 2 was 
exposed on Wednesdays, without hoods the 
first week and with hoods the second week. 
The participants wore only shorts during their 
6-hr exposures. They began a restricted diet 
and restricted use of personal care products 
12 hr before entering the chamber and 
continued these restrictions until the end of 
urine collection 66 hr later.
Restricted diet and restricted use of 
personal care products. To better distinguish 
differences in the concentrations of DEP and 
DnBP metabolites in urine resulting from the 
chamber exposure, the participants followed 
a restricted diet and avoided all personal 
care products from 12 hr before until 54 hr 
after exposure began. While on the restricted 
diet, participants were permitted only tap 
water, tea brewed with tap water, Swedish 
dried bread, and fruits with thick skins (e.g., 
bananas, oranges, melons). Avoidance of 
personal care products included no use of 
soaps, shampoos, deodorants, colognes, or 
toothpaste. Preliminary experiments were 
conducted with eight participants over a 
48-hr period to evaluate the efficacy of these 
restrictions. Background urine concentra-
tions were reduced to medians/means and 
ranges of 4.1/11.8 and 0.9–53 μg/L for 
mono-ethyl phthalate (MEP) and 7.4/10.7 
and 1.5–37 μg/L for mono-n-butyl phthalate 
(MnBP). The background levels achieved 
with restrictions were below median back-
ground levels in the general population 
[30 μg/L for MEP and 9.2 μg/L for MnBP 
for adult males sampled in 2011–2012 
(CDC 2015)] and more than two orders of 
magnitude below peak levels observed in the 
subsequent exposure experiments.
Breathing hoods and breathing air. 
Supplemental Material, Figure S1, shows 
one of the authors wearing a breathing 
hood. The breathing hoods and associated 
latex neck seals and hoses were purchased 
from Amron International, Vista, CA 
(#8890 Oxygen Treatment Hood). Samples 
cut from each were ultrasonically extracted 
with acetone and analyzed by GC/MS for 
both DEP and DnBP using a DB-5MS 
column and SIM (m/z 149); their levels 
were found to be negligible. The level of 
another phthalate plasticizer, di(2-ethyl-
hexyl) phthalate (DEHP), was quite high. 
However, the metabolites of DEHP differ 
from those of DEP and DnBP (Koch et al. 
2013), and do not interfere with the analyses 
of MEP, MnBP, and 3OH-mono-n-butyl 
phthalate (3OH-MnBP). The breathing air 
was compressed air that passed through both 
particulate and activated carbon filters before 
flowing through the hood at 50 L/min. It 
was not humidified. Between the first and 
second round of experiments, duplicate 1-hr 
air samples were collected from one of the 
breathing hoods under conditions similar to 
when the participants were wearing hoods. 
The measured levels of DEP in the hood with 
breathing air flowing through were 42.5 and 
39.0 μg/m3, and those of DnBP were 6.3 
and 5.0 μg/m3. Because negligible amounts 
of these phthalates had been measured in the 
hoods, neck seals, and hoses, we assume that 
the source of DEP and DnBP was upstream 
of the hoods. Based on these measurements, 
all doses reported during the period when 
the participants were wearing hoods were 
corrected for inhalation of DEP and DnBP 
in hood air assuming a breathing rate of 
0.7 m3/hr (U.S. EPA 2011). Further details 
are provided below (“Background corrections, 
hood air corrections, and normalizations”). 
Preparing the chamber for the exposure 
experiments. The exposure experiments 
were conducted at the Technical University 
of Denmark in a sparsely furnished 55-m3 
chamber in which air was mixed by two fans. 
Only one group at a time was exposed in the 
chamber. Each participant sat on a wire mesh 
chair at a small table and typically worked 
on a laptop computer while in the chamber. 
Supplemental Material, Figure S2, shows 
group 1 participants in the chamber wearing 
breathing hoods. The air exchange rate was 
maintained at 0.7/hr, and the temperature 
was controlled at 30°C. The relative humidity 
was not controlled and ranged between 20 
and 35% when the partici pants were in 
the chamber. Chamber conditions for the 
experiments are summarized in Supplemental 
Material, Table S3.
Latex paint, formulated with 1% DEP 
and 10% DnBP (by weight), was used to 
deliver these phthalates into chamber air at 
a relatively constant emission rate. Further 
details regarding the paint, including 
experiments conducted to determine the 
mass fraction of DEP and DnBP required 
to achieve the targeted steady-state air 
concentrations, were described by Schripp 
et al. (2014).
On Monday of the first exposure week, 
the latex paint spiked with DEP and DnBP 
was applied on each side of six aluminum 
plates (1 m × 1 m; total area of 12 m2) with 
a paint roller, and the plates were immedi-
ately placed in the chamber. The following 
Monday the panels were repainted following 
the same procedure. Each week, during the 
6-hr exposures that occurred on Tuesday 
and Wednesday, the gas-phase concentra-
tions of the two phthalates were determined 
on an hourly basis. The average gas-phase 
concentrations measured during the four 
exposure periods are shown in Table 1, and 
hourly values measured during the exposure 
periods are plotted in Supplemental Material, 
Figure S3. For the exposure periods when 
hoods were worn, the air concentrations 
of DEP and DnBP for group 1 were 12% 
lower than those for group 2, whereas for 
the exposure periods without hoods, the air 
concentrations for group 2 were about 20% 
lower than those for group 1 (Table 1).
Measurement of phthalate metabolites in 
urine. On the mornings of exposure, each 
participant collected one or two urine samples 
prior to entering the chamber; after entering 
the chamber, participants collected all urina-
tions for the next 54 hr—recording the 
time of the void for each individual sample. 
Urine voids were collected in 250-mL poly-
propylene specimen containers known to 
be phthalate free; during some urinations, 
more than one vessel was used to collect 
the urine. Field blanks were not collected, 
given the many different micro environments 
occupied by the participants after leaving 
the chamber. However, the target analytes—
MEP, MnBP, and 3OH-MnBP—are not 
common contaminants in indoor settings. 
The samples were weighed the day of collec-
tion and then stored in a freezer until they 
were shipped overnight to the Institute for 
Prevention and Occupational Medicine of 
the German Social Accident Insurance (the 
IPA) in Bochum, Germany. Samples were 
still frozen upon arrival.
Urine samples were analyzed for MEP, 
a metabolite of DEP, as well as MnBP and 
3OH-MnBP, metabolites of DnBP. The 
concentrations of these metabolites were deter-
mined by two-dimensional high-performance 
liquid chromatography coupled to tandem 
mass spectrometry (LC/LC–MS/MS) using 
internal isotope-labeled standards after 
enzymatic deconjugation of the phthalate 
metabolites from the glucuronidated form, 
following methods published by Koch et al. 
(2003, 2007) and Preuss et al. (2005). The 
Table 1. Average concentrations (minimum–maximum) of DEP and DnBP measured in the chamber 
during the 6-hr exposure intervals.
Day of exposure Group Status DEP (μg/m3) DnBP (μg/m3)
Tuesday, 1st week Group 1 Hoods 250 (240–280) 123 (120–132)
Wednesday, 1st week Group 2 No hoods 233 (225–252) 114 (108–122)
Tuesday, 2nd week Group 1 No hoods 291 (282–317) 140 (135–149)
Wednesday, 2nd week Group 2 Hoods 284 (240–353) 140 (122–163)
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limits of quantification (LOQs) for MEP, 
MnBP, and 3OH-MnBP were 0.25, 1.0, and 
0.25 μg/L, respectively. Quality control mate-
rials, prepared using pooled native urine from 
various individuals from the IPA to represent 
the general conjugation status (e.g., glucuroni-
dation) of all urine samples, and reagent blank 
samples were included in each batch together 
with the study samples. The laboratory 
that performed the analysis has successfully 
participated as a reference lab for phthalate 
metabolite analyses in the quality assessment/
quality assurance program of the European 
Union (EU)-financed Consortium to Perform 
Human Biomonitoring on a European Scale 
(Schindler et al. 2014). The creatinine concen-
tration in urine was measured according to the 
Jaffé method (Taussky 1954).
Chemical analysis. Air samples were 
collected using stainless-steel tubes filled with 
Tenax TA (Markes Ltd.) at 100 mL/min 
(6 L total sampling volume). The tubes were 
analyzed via thermal desorption (TD100, 
Markes Ltd.)/gas chromatography (6890 
Series GC System, Agilent)/mass spec-
trometry [5973N MSD (mass selective 
detector); Agilent] according to DIN ISO 
16000-6, (International Organization 
for  Standardizat ion 2012).  The GC 
was equipped with an HP5MS column 
(60 m × 250 μm × 0.3 μm); the oven 
temperature program was 30°C (1 min), then 
increased by 8°C/min to 280°C (5 min). The 
MSD was operated in selected ion monitoring 
mode (SIM) using m/z 149 (phthalates) and 
m/z 234 (internal standard). Substances were 
quantified on the basis of original standards. 
3-Bromo-biphenyl was used as an internal 
standard during sampling and analysis. The 
detection limit for DEP and DnBP as deter-
mined from the calibration curve (Einax et al. 
1997) was 1 μg/m3.
Calculating uptakes from metabolite 
concentrations measured in urine. We calcu-
lated the total uptake from the metabolite 
levels in urine using established proce-
dures (Koch et al. 2007, 2012, 2013). The 
molecular weights (g/mol) used to convert 
the metabolites to the parent compounds 
were as follows: DEP, 222.24; MEP, 
194.18; DnBP, 278.34; MnBP, 222.24; and 
3OH-MnBP, 238.24. Metabolic conver-
sion factors from metabolism studies (Koch 
et al. 2012) indicate the fraction of an (oral) 
dose of parent phthalate that is excreted as 
a specific metabolite in urine: DEP/MEP, 
approximately 0.84 (set by analogy to DnBP); 
DnBP/MnBP, 0.84; and DnBP/3OH-
MnBP, 0.07. DnBP uptake was calculated by 
summing both metabolites:
DnBP (μg) = {[(MnBP/222.24)  
 + (3OH-MnBP/238.24)] 
 × 278.34} ÷ (0.84 + 0.07). [1] 
DEP uptake was calculated as
DEP (μg) =  
[(MEP /194.18) × 222.24] ÷ 0.84. [2]
Background corrections, hood air correc-
tions, and normalizations. For each metabo-
lite, we summed the total amount excreted 
in urine samples collected from the time the 
participants entered the chamber until the 
last urine sample was collected about 54 hr 
later, making no adjustments. Using these 
values, the total doses of DnBP and DEP 
were calculated from Equations 1 and 2. 
The calculated total doses represent both the 
exposures that occurred during the 6 hr in 
the chamber as well as those that occurred 
outside the chamber from 6 to approxi-
mately 54 hr. Although participants were 
on a restricted diet, which limited ingestion 
of DEP and DnBP, they still inhaled and 
dermally absorbed “background” DEP and 
DnBP from the time they left the chamber 
at 6 hr until their final urine samples were 
collected at approximately 54 hr. For each 
participant, we can roughly estimate the dose 
that occurred in this 48-hr period outside the 
chamber by using the urine concentrations 
of metabolites measured in their urine just 
before entering the chamber coupled with 
the average volume of urine excreted by each 
participant in the 48-hr period after leaving 
the chamber. This gives us an estimate of DEP 
and DnBP uptake over the 48 hr after leaving 
the chamber. We subtracted this estimate of 
“background dose” from the calculated total 
dose to obtain an estimate of dose during the 
6 hr in the chamber. Finally, for the exposures 
when the participants were wearing hoods, 
we subtracted the amount of DEP and DnBP 
inhaled from hood air (170 and 24 μg, respec-
tively). The resulting values represent the dose 
during exposure in the chamber, corrected 
for background dose during the period from 
6 to 54 hr and also corrected for hood air 
inhalation intake for the chamber exposures 
that occurred while participants were wearing 
hoods. For each participant, the values of the 
parameters used in these calculations, as well 
as the final results, are listed in Supplemental 
Material, Table S4. Finally, for a given 6-hr 
exposure, total uptakes of DEP and DnBP 
were normalized first by the chamber air 
concentrations of DEP and DnBP and then 
by the participant’s body mass. Although 
the potential is small, there may be uptake 
misclassification due to imperfect correc-
tions for “background dose,” hood air, and 
differences in chamber air concentrations.
Results
Metabolite concentrations over time. Figure 1 
shows creatinine-normalized concentrations 
of MEP, MnBP, and 3OH-MnBP in urine 
samples of each participant collected from 
the time the participant entered the chamber 
until 54 hr later (no corrections have been 
made to the values). When the participants 
were exposed to elevated chamber concentra-
tions of DEP and DnBP, either wearing a 
hood or not wearing a hood, urine concen-
trations of MEP, MnBP, and 3OH-MnBP 
quickly rose, beginning with the initial urina-
tion that occurred after entering the chamber. 
The metabolite concentrations typically 
peaked in the first or second urination after 
the participants exited the chamber after 6 hr 
exposure, and levels remained elevated with 
respect to prechamber levels for at least the 
next 40 hr. Metabolite concentrations were 
lower when the participants were exposed to 
chamber air while wearing a hood, but the 
levels were still substantially higher than levels 
measured before the participants entered 
the chamber, indicating significant uptake 
of DEP and DnBP while participants were 
wearing a hood.
Net amount of metabolite excreted over 
time. For each participant, Figure 2 shows 
the net amount of MEP and MnBP excreted 
from the time exposure began until 54 hr 
later (no corrections have been made to the 
values). As anticipated, there is participant-
to-participant variability. However, for all 
participants there is substantial excretion 
of MEP and MnBP when they are exposed 
while wearing hoods (i.e., when exposure 
from chamber air is primarily via the dermal 
pathway). The net amount of MEP excreted 
when the participants were wearing hoods is 
roughly half that excreted when not wearing 
hoods; for MnBP, the fraction is somewhat 
less than half. It is also apparent from these 
plots that, during the initial 12 hr, the 
excreted amounts of both MEP and MnBP 
increased faster when participants were not 
wearing hoods than when wearing hoods.
Total uptake of DEP and DnBP esti-
mated from urinary metabolite levels. As 
described in “Methods,” the total uptake of 
DEP and DnBP can be back-calculated from 
the concentrations of their metabolites in a 
participant’s urine samples. Figure 3 displays 
box plots of the net uptakes (micrograms) of 
DEP and DnBP, corrected for background 
and hood air uptakes, and normalized by 
their measured air concentrations during 
each exposure experiment (micrograms per 
cubic meter, Table 1). Separate box plots are 
displayed for exposures without a hood (total), 
exposures with a hood (dermal), and the differ-
ences between these two uptakes (inhalation). 
The median value for dermal uptake of DEP 
is slightly higher than that for its inhalation 
intake [4.0 vs. 3.8 μg/(μg/m3 air)]. The median 
value for dermal uptake of DnBP is about 
80% of that for its inhalation intake [3.1 vs. 
3.9 μg/(μg/m3 air)].
Evidence for dermal uptake of phthalates from air
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Total uptakes normalized by air concentra-
tions and body weight. The final normali za tion 
that we made was to divide the net uptakes in 
Figure 3 by the body weight of each partici-
pant. Supplemental Material, Figure S4, shows 
a box plot displaying the micrograms of uptake 
per kilogram of body weight per microgram 
per cubic meter of air for exposures without a 
hood (total) and with a hood (dermal) and for 
the difference (inhalation). When the uptakes 
are normalized in this manner, the median 
dermal uptake of DEP is about 10% higher 
than its inhalation intake (0.048 vs. 0.043 μg 
uptake/kg body weight per μg/m3 air), and the 
dermal uptake of DnBP is 82% of its inhala-
tion intake (0.040 vs. 0.049 μg uptake/kg body 
weight per μg/m3 air).
Differences with age. In Figure 4, the 
normalized dermal and inhalation uptakes 
from air (micrograms of uptake/kilogram body 
weight per microgram per cubic meter of air) 
are plotted against the age of the participants. 
The older the participant, the higher were 
the dermal uptakes of both DEP and DnBP 
from air. Based on this limited sample of six, 
the impact of age is surprisingly strong. The 
uptake of DEP by the 66-year-old is five times 
greater than that of the 27-year-old, while 
the uptake of DnBP is seven times greater. 
The inhalation pathway also shows increasing 
uptake with increasing age for DnBP, but the 
trend is less pronounced for DEP. In the case 
of the dermal uptake, Spearman’s correlation 
coefficients (ρ) between uptake and age are 
0.9856 (p = 0.0003) and 1.0 (p = 0.0000) for 
DEP and DnBP, respectively; in the case of 
the inhalation uptake, ρ = 0.0286 (p = 0.9572) 
for DEP and ρ = 1.0 (p = 0.0000) for DnBP.
Although their power is weak, these correla-
tion coefficients support expectations based 
on visual inspection of Figure 4. They indicate 
that the trend for increased dermal uptake 
with increasing age is significant for DEP 
and DnBP, whereas the trend for increased 
inhalation uptake is significant for DnBP, 
but not DEP.
Discussion
Comparison of uptake via the dermal 
pathway with intake via inhalation pathway. 
Even when participants wore hoods, the 
urinary concentrations of MEP, MnBP, and 
3OH-MnBP (Figure 1), as well as the net 
amount of these metabolites excreted over 
time (Figure 2), increased significantly as a 
consequence of a 6-hr exposure to elevated air 
concentrations of DEP and DnBP. Increases 
were much higher than could be explained by 
DEP and DnBP in hood air (see Supplemental 
Material, Table S4). In addition, when partici-
pants wore hoods, the total uptakes of DEP 
and DnBP estimated from urinary metabolite 
levels—corrected for background and hood air 
uptakes and normalized by air concentrations 
(Figure 3) as well as both air concentrations 
and body weight (see Supplemental Material, 
Figure S4)—indicate substantial dermal uptake 
of DEP and DnBP directly from chamber air.
Volume of air inhaled during 6-hr 
exposure. In Figure 3, where the uptake 
amounts (micrograms) were normalized by 
the measured air concentrations (micro-
grams per cubic meter), the resulting units 
are cubic meters. For inhalation intakes, this 
value should correspond to the cubic meters 
of air inhaled during the 6-hr exposure in 
the chamber. The median values shown for 
inhalation intakes (3.8 m3 for DEP and 
3.9 m3 for DnBP) are remarkably close to the 
value predicted for an adult male at rest and 
breathing at a rate of 0.7 m3/hr (U.S. EPA 
2011) during a 6-hr period (4.2 m3).
Comparison with predicted absorption 
from air. Although these experiments indicate 
substantial dermal uptake directly from air 
for both DEP and DnBP, the measured 
values for the contribution of the dermal 
pathway directly from air are lower than those 
predicted in recent studies (Weschler and 
Nazaroff 2012, 2014; Gong et al. 2014b). 
The ratio of dermal uptake to inhalation 
intake predicted by Weschler and Nazaroff 
(2012, 2014) are based on a steady-state 
model. However, dynamic modeling (Gong 
et al. 2014b) indicated that more than 48 hr 
would be required to reach steady state in the 
instance of DEP and DnBP; the participants 
were exposed to elevated concentrations in 
the chamber for only 6 hr. At the time the 
participants left the chamber, a large fraction 
of the DEP and DnBP absorbed by the skin 
(> 97%) was predicted to be still in the skin. 
In addition to diffusing into the dermal capil-
laries, the DEP and DnBP in the skin can 
desorb to air and the clothing the participants 
put on after exiting the chamber. Bathing is 
another sink. Therefore, in the present study 
we asked participants not to shower for at least 
24 hr after leaving the chamber, but this did 
not preclude hand washing. Desorption from 
skin to air and clothing, from the time the 
participants left the chamber until the time 
Figure 1. Concentrations (creatinine-normalized) of MEP, MnBP, and 3OH-MnBP in urine samples from the 
six participants (P1–P6) collected shortly before entering the chamber until 54 hr after the 6-hr exposure 
began. No adjustments were made to the values other than normalization by creatinine. 
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the last urine sample was collected, coupled 
with washing, would meaningfully reduce the 
dermal uptake of DEP and DnBP. Gong et al. 
(2014b) did not take clothing and washing 
into account in their transient model; thus, 
their model over predicts the amount of 
DEP and DnBP that reaches the blood for 
the period from when participants leave the 
chamber until their last urine sample.
Dermal absorption occurred both on 
the exposure days that the participants wore 
hoods and the days without hoods. The lag 
between dermal absorption and uptake into 
the blood is apparent from the fact that, 
although the urine concentrations of MEP, 
MnBP, and 3OH-MnBP peaked shortly after 
the participants left the chamber, the urine 
concentrations were still two or more times 
greater than background 40 hr after leaving 
the chamber. Such a lag between exposure 
and excretion was not observed when a partic-
ipant ingested a known amount of labeled 
DnBP (Koch et al. 2012), nor would it be 
anticipated for inhalation of DEP or DnBP.
Under typical indoor conditions, occu-
pants tend to be much closer to steady state 
because they are continuously exposed to DEP 
and DnBP in home and work environments. 
Note that the chamber concentrations were 
roughly two orders of magnitude higher 
than typical indoor levels so we could distin-
guish chamber exposures from daily life 
exposures (e.g., Fromme et al. 2004; Rudel 
et al. 2003; Wensing et al. 2005; Weschler 
and Nazaroff 2008). On the other hand, 
clean clothing may retard dermal uptake 
from air, and bathing may remove DEP and 
DnBP temporarily sorbed in the stratum 
corneum. In other words, although people 
may be closer to steady-state conditions in 
daily life, resulting in larger ratios of dermal-
to-inhalation uptakes than measured in the 
present study, other exposure variables may 
have an opposing influence.
Differences with age. The finding that 
DEP and DnBP dermal uptake was larger for 
older participants than for younger partici-
pants (Figure 4) was unanticipated. The skin’s 
barrier function is influenced by both its 
thickness and its lipid content. Although the 
number of epidermal skin cell layers is similar 
in older and younger humans, older skin has 
a thinner epidermis (i.e., it is more compact) 
and has less lipids than younger skin (Harvell 
and Maibach 1994; WHO 2006). The net 
effect of these changes on dermal absorption 
remains unclear. Roskos et al. (1989) applied 
various chemicals, radiolabeled with 14C, to 
the inside surface of the forearms of younger 
(22–40 years) and older (> 65 years) human 
participants. Absorption was assessed using 
standard radio tracer methodology on urine 
samples collected for a week following applica-
tion. Dermal penetration of four hydrophilic 
compounds (hydro cortisone, benzoic acid, 
acetyl salicylic acid, and caffeine) was signifi-
cantly lower in the older participants than 
in the younger participants, whereas dermal 
penetration of two lipophilic compounds 
(testosterone and estradiol) was not statistically 
different between the groups. Both DEP and 
DnBP are lipophilic compounds. In a review 
of dermal absorption in aged skin, Harvell 
and Maibach (1994) concluded that opinions 
regarding differences in percutaneous absorp-
tion between young and old skin “are far from 
a consensus,” and experiments addressing 
this issue remain non-definitive. This is 
also the position summarized in a WHO 
Environmental Health Criteria document on 
dermal absorption (WHO 2006). We found 
no studies in the peer-reviewed literature that 
examined dermal uptake of organic vapors 
directly from air as a function of age. We 
recognize that the strong relationship shown 
in Figure 4 may be due to random error or 
uncontrolled sources of bias, and we recom-
mend further studies addressing this issue 
because it has implications for risk assessments 
in older populations.
Figure 2. Net amount of MEP and MnBP excreted by each of the six participants (P1–P6) from the time exposure began until 54 hr later. No adjustments were 
made to the values. 
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Metabolism of phthalates in skin. Using 
viable skin samples and diffusion cells, Beydon 
et al. (2010) measured dermal permea tion and 
metabolism of DnBP in samples from humans 
and other animals. They found that carboxyl-
esterases in skin hydrolyzed DnBP to MnBP 
in all of the species studied and that inhibition 
of carboxyl esterase activity retarded passage of 
DnBP through the skin. In the case of DEHP, 
a high-molecular-weight phthalate, Hopf et al. 
(2014) found that it was metabolized to the 
monoester MEHP in viable human skin and 
that MEHP, rather than the parent phthalate, 
passed into receptor fluid in a diffusion cell. 
Modeling has indicated that for DEHP, the 
viable epidermis presents greater resistance 
to transport than does the stratum corneum; 
conversely for DEP and DnBP, resistance 
across the stratum corneum is greater than 
across the viable epidermis (Weschler and 
Nazaroff 2012). This is significant because if 
metabolism occurs in the viable epidermis but 
not the stratum corneum, it will have a larger 
impact on the overall rate of dermal uptake for 
DEHP than for DEP and DnBP. Hopf et al. 
(2014) assumed that DEHP first permeates 
the stratum corneum and is then hydrolyzed, 
arguing that cutaneous esterases are generally 
not present in the stratum corneum. Beydon 
et al. (2010) measured carboxyl esterase activity 
in the epidermis and found that it was only 
4.2% of that in whole skin. Although this 
finding does not distinguish between metabo-
lism in the stratum corneum and viable 
epidermis, it does indicate greater metabolism 
after DnBP has passed through the epidermis 
(i.e., stratum corneum and viable epidermis). 
If, indeed, there is very little metabolic activity 
in the stratum corneum, then in terms of 
risk assessment it probably does not matter 
a great deal whether hydrolysis of DEP and 
DnBP occurs before or after the phthalate 
enters the blood. However, such a conclusion 
requires that the relative dermal toxicity of 
the monoester is comparable to that of the 
parent compound.
Impact of clothing. In the present study 
the human participants wore only shorts; the 
rest of their skin was directly exposed to air. 
A preliminary evaluation of the impact of 
clothing on these exposures was conducted 
concurrently with this study and has been 
described by Morrison et al. (2015).
Other phthalates. For dermal uptake 
directly from air to contribute significantly 
to total body burden, an organic compound 
must possess the right physical–chemical 
properties—a relatively large value for its skin 
lipid/air partition coefficient (Ksc_g) and a 
relatively small molecular weight (Weschler 
and Nazaroff 2012, 2014; Gong et al. 
2014b). Although most phthalate esters have 
values for Ksc_g that are favorable for dermal 
absorption from air, higher-molecular-weight 
phthalates such as butyl benzylphthalate 
(BBzP), di(2-ethylhexyl) phthalate (DEHP), 
and di(isononyl) phthalate (DiNP) tend 
to have low gas-phase concentrations. This 
results in kinetic constraints on the flux 
from air to skin; it is too small for dermal 
uptake from air to be an important pathway 
for compounds such as DEHP and DiNP. 
Although DEHP has been measured at high 
levels in skin wipes (Gong et al. 2014a; 
Kim HH et al. 2011), this likely reflects 
transfer to skin via contact with DEHP 
contaminated surfaces. In summary, dermal 
absorption directly from indoor air should be 
included as a contributory exposure pathway 
in risk assessments of low-molecular-weight 
phthalates, but this pathway is anticipated to 
be of decreasing importance with increasing 
molecular weight.
Conclusions
This study has demonstrated that for human 
participants following a 6-hr dermal-only 
exposure to elevated gas-phase concentrations 
of DEP and DnBP, the levels of the metabo-
lites MEP, MnBP, and 3OH-MnBP in 
urine samples collected over the next 2 days 
were roughly half those measured in urine 
samples following a 6-hr dermal plus inhala-
tion exposure. Although earlier assessments 
of human exposure to phthalate esters have 
included the dermal pathway (e.g., Guo and 
Kannan 2011; Koch et al. 2013; Wittassek 
et al. 2011; Wormuth et al. 2006), it is only 
recently that dermal absorption directly from 
air has been part of such assessments (Bekö 
et al. 2013; Gaspar et al. 2014). The present 
study provides support for including this 
pathway in risk assessments. However, the 
ratios of dermal uptake to inhalation intake 
for DEP and DnBP assumed in the modeling 
studies of Bekö et al. (2013) and Gaspar et al. 
(2014) are higher than those measured in the 
current study. This apparent disparity may 
reflect the fact that in our study the partici-
pants were exposed to elevated levels of DEP 
and DnBP for only 6 hr, whereas dynamic 
modeling indicates that > 40 hr would be 
required to reach steady-state and maximal 
uptake via the dermal pathway in comparison 
to the inhalation pathway.
Figure 3. Box plots displaying the uptakes (μg) of DEP and DnBP, corrected for uptakes occurring outside 
the chamber and from hood air, normalized by measured chamber air concentrations during each 
exposure experiment (μg/m3; Table 1), for exposures without a hood (total) and exposures with a hood 
(dermal), and for the differences between these two uptakes (inhalation). Boxes extend from the 25th 
to the 75th percentile, horizontal lines represent the median, and whiskers indicate the 10th and 90th 
percentiles. The symbols indicate individual results for each of the six participants (P1–P6). 
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Figure  4. Dermal and inhalation uptakes from 
chamber air, corrected for uptakes occurring 
outside the chamber and from hood air, and 
normalized by chamber air concentrations and 
body weight plotted against the age of the six 
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